Skip to main content

Table 2 CRS and HIPEC procedures performed in 53 patients with (n = 21) or without (n = 32) “neoajuvant” PIPAC

From: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Patients

All

(n = 53)

Primary CRS and HIPEC

(n = 32)

Secondary CRS and HIPEC (after PIPAC)

(n = 21)

Number of CRS and HIPEC

 -Single procedure

 -Repeated HIPEC

57

53

4

36

32

4

21

21

0

Completeness of cytoreduction (CC) score

 -CC-0

 -CC-1

 -CC-2

39 (74 %)

12 (22 %)

2 (4 %)

22 (69 %)

9 (28 %)

1 (3 %)

17 (81 %)

3 (14 %)

1 (5 %)

Number of PIPAC before HIPEC

 1

 2

 3

 4

 5

12

0

4

4

1

N/A

N/A

N/A

N/A

N/A

12

0

4

4

1

Downstaginga

 -Histology

 -Radiology

N/A

N/A

N/A

N/A

8/9

7/9

  1. N/A non available
  2. aOut of nine patients with ≥2 PIPAC